1-234607140-CGA-C
Variant summary
Our verdict is Uncertain significance. The variant received 4 ACMG points: 4P and 0B. PVS1_ModeratePM2
The NM_182972.3(IRF2BP2):c.1759_1760delTC(p.Ser587ValfsTer14) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★). Synonymous variant affecting the same amino acid position (i.e. S587S) has been classified as Likely benign.
Frequency
Consequence
NM_182972.3 frameshift
Scores
Clinical Significance
Conservation
Publications
- immunodeficiency, common variable, 14Inheritance: AD, Unknown Classification: LIMITED Submitted by: ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IRF2BP2 | NM_182972.3 | c.1759_1760delTC | p.Ser587ValfsTer14 | frameshift_variant | Exon 2 of 2 | ENST00000366609.4 | NP_892017.2 | |
IRF2BP2 | NM_001077397.1 | c.1711_1712delTC | p.Ser571ValfsTer14 | frameshift_variant | Exon 2 of 2 | NP_001070865.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IRF2BP2 | ENST00000366609.4 | c.1759_1760delTC | p.Ser587ValfsTer14 | frameshift_variant | Exon 2 of 2 | 1 | NM_182972.3 | ENSP00000355568.3 | ||
IRF2BP2 | ENST00000366610.8 | c.1711_1712delTC | p.Ser571ValfsTer14 | frameshift_variant | Exon 2 of 2 | 1 | ENSP00000355569.3 | |||
ENSG00000228830 | ENST00000436039.1 | n.135_136delAG | non_coding_transcript_exon_variant | Exon 1 of 2 | 3 | |||||
IRF2BP2 | ENST00000491430.1 | n.*89_*90delTC | downstream_gene_variant | 1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not provided Uncertain:1
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site, but this prediction has not been confirmed by published transcriptional studies. This variant has not been reported in the literature in individuals with IRF2BP2-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change results in a frameshift in the IRF2BP2 gene (p.Ser587Valfs*14). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 1 amino acid(s) of the IRF2BP2 protein and extend the protein by 12 additional amino acid residues. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at